$3.00
0.000.00%
At close: -
$3.05
0.051.60%
After Hours: 5:24 PM EDT
Comments
Loading...
Aquestive Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AQST | Benzinga
Aquestive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$12.23M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$57.56M
Analyze the earnings history of Aquestive Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics | -$0.17 | -$0.16 | — | — | $12.05M | $12.23M | — | — | 05/12/2025 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.10 | -$0.13 | -$0.19 | -46.15% | $13.21M | $13.11M | $11.87M | -9.48% | 03/05/2025 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.03 | -$0.13 | -$0.13 | 0.00% | $13.00M | $12.68M | $13.54M | 6.80% | 11/04/2024 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.10 | -$0.12 | -$0.03 | 75.00% | $13.24M | $12.38M | $20.10M | 62.35% | 08/06/2024 | Get Alert |
| AQST | Aquestive Therapeutics | $0.11 | -$0.08 | -$0.17 | -112.50% | $11.13M | $12.26M | $12.05M | -1.69% | 05/07/2024 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.23 | -$0.08 | -$0.10 | -25.00% | $10.68M | $11.63M | $13.21M | 13.55% | 03/05/2024 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.23 | -$0.11 | -$0.03 | 72.73% | $11.46M | $11.51M | $13.00M | 12.96% | 11/06/2023 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.36 | -$0.11 | -$0.10 | 9.09% | $13.27M | $10.76M | $13.24M | 23.06% | 08/07/2023 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.32 | -$0.19 | $0.11 | 157.89% | $12.27M | $9.94M | $11.13M | 12.01% | 05/02/2023 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.38 | -$0.23 | -$0.23 | 0.00% | $11.08M | $10.42M | $10.68M | 2.51% | 03/07/2023 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.37 | -$0.30 | -$0.23 | 23.33% | $13.29M | $11.04M | $11.46M | 3.83% | 11/01/2022 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.33 | -$0.36 | -$0.36 | 0.00% | $15.35M | $10.57M | $13.27M | 25.50% | 08/02/2022 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.41 | -$0.41 | -$0.32 | 21.95% | $11.12M | $10.11M | $12.27M | 21.36% | 05/03/2022 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.60 | -$0.47 | -$0.38 | 19.15% | $7.15M | $9.36M | $11.08M | 18.35% | 03/08/2022 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.49 | -$0.45 | -$0.37 | 17.78% | $8.26M | $11.01M | $13.29M | 20.68% | 11/02/2021 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.07 | -$0.44 | -$0.33 | 25.00% | $21.68M | $9.48M | $15.35M | 61.87% | 08/03/2021 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.49 | -$0.43 | -$0.41 | 4.65% | $8.77M | $8.97M | $11.12M | 23.99% | 05/04/2021 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.48 | -$0.26 | -$0.60 | -130.77% | $16.42M | $6.25M | $7.15M | 14.38% | 03/09/2021 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.54 | -$0.46 | -$0.49 | -6.52% | $12.42M | $8.72M | $8.26M | -5.28% | 11/04/2020 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.82 | -$0.43 | -$0.07 | 83.72% | $11.13M | $8.77M | $21.68M | 147.15% | 08/04/2020 | Get Alert |
| AQST | Aquestive Therapeutics | -$0.59 | -$0.47 | -$0.49 | -4.26% | $12.64M | $10.07M | $8.77M | -12.96% | 05/05/2020 | Get Alert |
Aquestive Therapeutics (AQST) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $-0.19 | $-0.13 | -46.2 % |
| Q3 | 2024-11-04 | $-0.13 | $-0.13 | 0.00 % |
| Q2 | 2024-08-06 | $-0.03 | $-0.12 | 75.0 % |
| Q1 | 2024-05-07 | $-0.17 | $-0.08 | -112.5 % |
Aquestive Therapeutics (AQST) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $11.87M | $13.11M | -9.48 % |
| Q3 | 2024-11-04 | $13.54M | $12.68M | 6.80 % |
| Q2 | 2024-08-06 | $20.10M | $12.38M | 62.4 % |
| Q1 | 2024-05-07 | $12.05M | $12.26M | -1.69 % |
FAQ
When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?
Aquestive Therapeutics (AQST) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
What were the latest earnings per share (EPS) for Aquestive Therapeutics (NASDAQ:AQST)?
The Actual EPS was $-0.19, which missed the estimate of $-0.13.
What were Aquestive Therapeutics’s (NASDAQ:AQST) revenues?
The Actual Revenue was $11.9M, which missed the estimate of $13.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
